Abstract: In general, according to one embodiment, a nonaqueous electrolyte battery is provided. The nonaqueous electrolyte battery includes an electrode group, including a positive electrode, a negative electrode, and a separator. The separator includes at least one metal-element containing portion containing a metal element. The at least one metal-element containing portion is provided on a surface of the separator in contact with the negative electrode. The at least one metal-element containing portion contains at least one selected from a group consisting of a metal, a metallic oxide, and a metallic fluoride. An area of the at least one metal-element containing portion is in a range of 0.3 mm2 to 3.2 mm2.

Abstract: An ink jet ink composition includes a coloring material, a water-soluble organic solvent, and water. The coloring material contains a compound (A) having Cr (chromium) as Me in a structure represented by formula (1) below, and a compound (B) having Co (cobalt) as Me in the structure represented by the formula (1) below, and the mass ratio of the compound (B) to the compound (A) is over 0 and 0.06 or less.

Abstract: An ink jet textile-printing ink composition according to the present disclosure contains an acidic dye having water solubility of 30 g/L or less at 20° C., a water-soluble organic solvent, and water, wherein a glycol-based solvent and a cyclic-amide-based solvent are contained as the water-soluble organic solvent, and the cyclic-amide-based solvent contains one or both of ?-caprolactam and N-hydroxyethyl-2-pyrrolidone.

Abstract: The present disclosure provides method of preventing, lessening the effects, or treating cytokine release syndrome (CRS) or related disorders, and/or neurotoxicity associated with immunotherapy comprising administering defibrotide. The defibrotide can be administered after the immunotherapy begins or be administered prophylactically before immunotherapy begins or before the patient develops CRS and/or neurotoxicity.

Abstract: A compressor includes a compression mechanism, an electric motor unit, a drive shaft and a housing. A portion of the drive shaft, which is located on one side in an axial direction, is rotatably supported by a main bearing, which is formed integrally in one-piece with or is fixed to a main bearing member of the compression mechanism. Another portion of the drive shaft, which is located on another side in the axial direction, is rotatably supported by a sub-bearing, which is formed integrally in one-piece with or is fixed to an inside of a body portion of a sub-bearing member. The sub-bearing member is formed separately from the housing and is fixed to a bottom surface of a bottom portion of the housing.

Abstract: The present disclosure provides method of preventing, lessening the effects, or treating cytokine release syndrome (CRS) or related disorders, and/or neurotoxicity associated with immunotherapy comprising administering defibrotide. The defibrotide can be administered after the immunotherapy begins or be administered prophylactically before immunotherapy begins or before the patient develops CRS and/or neurotoxicity.

Abstract: The present invention relates to the treatment of subjects having a CD20-positive cell proliferative disorder. More specifically, the invention pertains to the treatment of subjects having a CD20-positive cell proliferative disorder by administering a combination of mosunetuzumab and polatuzumab vedotin.

Abstract: An ink composition for ink jet textile printing of the present disclosure contains a color material, a water-soluble organic solvent, and water, and the color material contains a color material A represented by Formula (1) below, a color material B represented by Formula (2) below, and a color material C that has a triazine structure and is different from the color material A and the color material B.

Abstract: An aqueous ink jet ink composition of the present disclosure contains a color material represented by Formula (1) below, a water-soluble organic solvent, and water. The color material represented by Formula (1) below contains two or more alkali metal ions as counterions, and the counterions include at least a sodium ion. (In Formula (1), M represents a counterion.

Abstract: A textile printing method for printing on a fabric, the fabric being a nonwoven fabric containing synthetic fibers. includes a first adhering step of adhering to the fabric by ejecting a dyeing ink by an ink jet method, and a second adhering step of adhering a non-dyeing ink to the fabric. The dyeing ink contains a disperse dye, a water-soluble organic solvent, and water, and the non-dyeing ink contains a water-soluble organic solvent and water. The water-soluble organic solvent contained in the non-dyeing ink contains a glycol-based organic solvent having a HSP value of 13.6 or more, and the content of the glycol-based organic solvent is 80% by mass or more relative to the total amount of the organic solvent contained in the non-dyeing ink. The adhesion position of the dyeing ink and the adhesion position of the non-dyeing ink are at least partially overlapped each other.

Abstract: An ink jet ink composition contains a color material, an organic solvent, and water. The ink jet ink composition contains N-hydroxyethylpyrrolidone and N-vinyl-2-pyrrolidone as the organic solvent.

Abstract: The present disclosure provides method of preventing, lessening the effects, or treating cytokine release syndrome (CRS) or related disorders, and/or neurotoxicity associated with immunotherapy comprising administering defibrotide. The defibrotide can be administered after the immunotherapy begins or be administered prophylactically before immunotherapy begins or before the patient develops CRS and/or neurotoxicity.

Abstract: An ink jet recording apparatus includes a textile printing ink composition and a liquid ejecting head including a nozzle that ejects the textile printing ink composition, where the textile printing ink composition contains an aqueous dye, an aqueous organic solvent, and water, a content of the aqueous dye with respect to a total amount of the textile printing ink composition is 10% by mass or more, and the liquid ejecting head includes the nozzle that ejects the textile printing ink composition, a pressure chamber to which the textile printing ink composition is supplied, and a circulation channel configured to circulate the textile printing ink composition supplied to the pressure chamber.

Abstract: An ink jet textile printing ink contains at least one water-soluble dye selected from the group consisting of acid dyes, reactive dyes, and direct dyes, a nonionic surfactant with a content in the range of 0.05% by mass to 3.0% by mass relative to the total mass of the ink, and an anionic surfactant with a content in the range of 1 ppm by mass to 100 ppm by mass relative to the total mass of the ink.

Abstract: An ink composition contains a first dye represented by formula (I) and a second dye represented by formula (II)

Abstract: An ink jet textile printing penetrant includes a water-soluble organic solvent; a surfactant; and one type or two or more types selected from the group consisting of a chelating agent and an aromatic compound.

Abstract: An ink jet textile printing ink composition according to the invention contains Li+, Na+, and a compound represented by the following formula (1):

Abstract: An ink jet textile printing ink contains at least one water-soluble dye selected from the group consisting of acid dyes, reactive dyes, and direct dyes, a nonionic surfactant with a content in the range of 0.05% by mass to 3.0% by mass relative to the total mass of the ink, and an anionic surfactant with a content in the range of 1 ppm by mass to 100 ppm by mass relative to the total mass of the ink.

Abstract: An ink composition contains a first dye represented by formula (I) and a second dye represented by formula (II).

Abstract: An ink jet textile printing ink composition according to the invention contains Li+, Na+, and a compound represented by the following formula (1):